
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings is projected to achieve total revenues of $890 million in 2026, reflecting an anticipated 17% increase over preliminary 2025 results, signaling strong growth momentum in the company's operations. The positive performance metrics, including a 28% year-over-year increase in overall surgical volumes and significant growth rates in new surgeon adoption (26%) and established territory revenue (30%), underscore the company's successful expansion within the spinal surgery market. Furthermore, the adjusted EBITDA of $26 million, exceeding expectations, indicates robust financial health and margin improvement, supporting a favorable outlook for Alphatec's stock performance.
Bears say
The analysis indicates a negative outlook for Alphatec Holdings due to anticipated lower revenue growth in the U.S. market and a reduction in free cash flow, which suggests potential challenges in sustaining financial performance. The company's guidance for a 10% growth from Q3 to Q4 2025, in contrast to a stronger sequential growth of 14% from Q2 to Q3 2025, further highlights a potential deceleration in sales momentum. Additionally, the ongoing risks associated with poor sales execution, increased competition, and potential disruptions from the COVID-19 pandemic present further concerns for investors regarding the company's future profitability.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares